Clinical Trial Update: Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating lenvatinib in gastrointestinal stromal tumor (GIST) patients after progression on imatinib, su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: Asan Medical Center | Conditions: GIST | Phase 1, Phase 2 | Status: RECRUITING